All News

ORSINGER OUT AT DEPUY SYNTHES. J&J REORGANIZES DEVICE BUSINESS

Walter Eisner • Fri, May 8th, 2015 Michel Orsinger is out as head of Johnson & Johnson’s (J&J) DePuy Synthes orthopedics business following a reorganization of J&J’s medical device businesses. Single Medical Devices Group The company is creating a single

InVivo Therapeutics Reports 2015 First Quarter Financial Results and Business Update

CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the quarter ended March 31, 2015. Mark Perrin, the CEO and Chairman of InVivo, said, “We continued to make great progress in the first quarter. We reported very encouraging

Texas Children’s Hospital welcomes Dr. John Dormans as chief of orthopedics

HOUSTON, May 8, 2015 /PRNewswire-USNewswire/ — Texas Children’s Hospital is excited to announce the addition of Dr. John Dormans as the new chief of orthopedics. Dormans, whose appointment will be effective May 1, will also serve as a professor of orthopedic surgery at Baylor College of Medicine. For

THE OPIOID EPIDEMIC AND ITS IMPACT ON ORTHOPAEDIC CARE

ROSEMONT, Ill., May 7, 2015 /PRNewswire-USNewswire/ — The United States makes up less than five percent of the world’s population but consumes 80 percent of the global opioid supply and approximately 99 percent of all hydrocodone—the most commonly prescribed opioid in the world. And, according to

SpineGuard Announces Adoption of Its DSG® Technology by the 15th French-Based Spine-Teaching Institution

PARIS & SAN FRANCISCO–(BUSINESS WIRE)–SpineGuard (FR0011464452 – ALSGD), an innovative company that designs, develops and markets disposable medical devices intended to make spine surgery safer, announced today the adoption of PediGuard by a 15thFrench University Hospital specializing in spine surgery:

Amedica Corporation Reports Fourth Quarter and Full Year 2014 Financial Results

SALT LAKE CITY, March 5, 2015 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced financial results for the fourth quarter and full year ended December 31, 2014.

Bone Biologics Corp Completes Financing With Hankey Capital, LLC

EDISON, N.J., May 6, 2015 /PRNewswire/ — Bone Biologics, Corp., (“Bone Biologics”) announced today the completion of a $2M funding round with Hankey Capital, LLC (“Hankey Capital”) of Los Angeles, CA. The company is developing a proprietary protein for use

Ceterix Orthopaedics Announces $35 Million In New Funding

MENLO PARK, Calif.–(BUSINESS WIRE)–Ceterix® Orthopaedics today announced that it has entered into a term loan agreement with CRG and certain of its affiliate funds, providing Ceterix with up to $35 million of available borrowing capacity. “We are excited have further

LinkSPINE Announces FDA (510)k Clearance of FacetLINK Fixation Platform

Rockaway, NJ – LinkSPINE, a company focused upon simple, less invasive implants and techniques for spinal surgery, is pleased to announce FDA (510)k Clearance of FacetLINK. FacetLINK uses two screws and a novel plated cross-connector assembly to stabilize the spine

New Fixes for Worn Knees

Scientists test implanting an artificial meniscus or inducing the body to grow a new one By MELINDA BECK Scientists have created artificial replacements for arms, legs, joints and other body parts. But developing an artificial meniscus—the shock-absorbing cartilage pad in

© 2024 MedDeviceJobs.com Powered by Careerleaf
v.4.3.2